These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 2907077

  • 1. [Acute manifestations in Crohn disease and ulcerative colitis. Conservative treatment of acute situations].
    Goebell H.
    Langenbecks Arch Chir; 1988; Suppl 2():77-81. PubMed ID: 2907077
    [Abstract] [Full Text] [Related]

  • 2. [Long-term therapy and timing of surgical intervention in ulcerative colitis and Crohn disease].
    Goebell H, Eigler FW.
    Chirurg; 1992 Jan; 63(1):8-12. PubMed ID: 1347737
    [No Abstract] [Full Text] [Related]

  • 3. [Conservative therapy of ulcerative colitis and Crohn disease].
    Rasenack J, Kreisel W.
    Fortschr Med; 1991 Apr 10; 109(11):245-7. PubMed ID: 1855750
    [Abstract] [Full Text] [Related]

  • 4. [Current therapeutic possibilities in chronic inflammatory intestinal diseases].
    Schölmerich J.
    Praxis (Bern 1994); 1995 Jan 10; 84(2):29-33. PubMed ID: 7839043
    [Abstract] [Full Text] [Related]

  • 5. [Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid].
    Feurle GE, Helmstädter V.
    Dtsch Med Wochenschr; 1986 May 02; 111(18):721-2. PubMed ID: 2870908
    [No Abstract] [Full Text] [Related]

  • 6. [5-Aminosalicylic acid in ulcerative colitis and Crohn's disease (author's transl)].
    Maier K, Fischer C, Klotz U, Heinkel K.
    Dtsch Med Wochenschr; 1982 Jul 23; 107(29-30):1131-4. PubMed ID: 6123426
    [Abstract] [Full Text] [Related]

  • 7. [Successful acute treatment of chronic inflammatory intestinal diseases with oral 5-aminosalicylic acid].
    Maier K, Frühmorgen P, Bode JC, Heller T, von Gaisberg U, Klotz U.
    Dtsch Med Wochenschr; 1985 Mar 08; 110(10):363-8. PubMed ID: 2857633
    [Abstract] [Full Text] [Related]

  • 8. Medical therapy for ulcerative colitis in childhood.
    Ament ME, Vargas JH.
    Semin Pediatr Surg; 1994 Feb 08; 3(1):28-32. PubMed ID: 7914811
    [Abstract] [Full Text] [Related]

  • 9. [Drug therapy of chronic inflammatory intestinal diseases--current status of 5-aminosalicylic acid].
    Schölmerich J, Gerok W.
    Wien Klin Wochenschr; 1986 Nov 21; 98(22):762-9. PubMed ID: 2880425
    [Abstract] [Full Text] [Related]

  • 10. Sulfasalazine and 5-ASA compounds.
    Allgayer H.
    Gastroenterol Clin North Am; 1992 Sep 21; 21(3):643-58. PubMed ID: 1355468
    [Abstract] [Full Text] [Related]

  • 11. Medical management of patients with difficult-to-treat inflammatory bowel disease.
    van Hogezand RA.
    Neth J Med; 1994 Aug 21; 45(2):55-9. PubMed ID: 7936006
    [Abstract] [Full Text] [Related]

  • 12. Medical treatment of inflammatory bowel disease: new therapies, new drugs.
    Sutherland LR.
    CMAJ; 1987 Nov 01; 137(9):799-802. PubMed ID: 2894889
    [Abstract] [Full Text] [Related]

  • 13. Chemistry, pharmacology, pharmacokinetics, and clinical applications of mesalamine for the treatment of inflammatory bowel disease.
    Small RE, Schraa CC.
    Pharmacotherapy; 1994 Nov 01; 14(4):385-98. PubMed ID: 7937276
    [Abstract] [Full Text] [Related]

  • 14. [Drug treatment of chronic inflammatory intestinal diseases with special reference to 5-azosalicylic acid].
    Fahrländer H.
    Schweiz Med Wochenschr; 1987 Oct 17; 117(42):1620-3. PubMed ID: 3321418
    [Abstract] [Full Text] [Related]

  • 15. Sulfasalazine and new analogues.
    Friedman G.
    Am J Gastroenterol; 1986 Feb 17; 81(2):141-4. PubMed ID: 2868653
    [No Abstract] [Full Text] [Related]

  • 16. [Local or systemic treatment of inflammatory bowel diseases?].
    Schmassmann A, Halter F.
    Ther Umsch; 1993 Feb 17; 50(2):94-9. PubMed ID: 8096092
    [Abstract] [Full Text] [Related]

  • 17. [Ulcerative colitis and Crohn disease. Early diagnosis and therapy].
    Wienbeck M, Purrmann J, Miller B.
    Internist (Berl); 1986 Mar 17; 27(3):166-71. PubMed ID: 2872183
    [No Abstract] [Full Text] [Related]

  • 18. [Drug safety, acceptance and effectiveness of 5-aminosalicylic acid (mesalazine) in the treatment of ulcerative colitis and Crohn disease].
    Bayerdörffer E, Bock H.
    Leber Magen Darm; 1988 Apr 17; 18(2):104-13. PubMed ID: 3374251
    [Abstract] [Full Text] [Related]

  • 19. [5-aminosalicylic acid in the treatment of ulcerative colitis and Crohn's disease].
    Moum B.
    Tidsskr Nor Laegeforen; 2003 Sep 25; 123(18):2565-7. PubMed ID: 14714043
    [Abstract] [Full Text] [Related]

  • 20. Topical salicylate therapy (4-ASA and 5-ASA enemas).
    Ginsberg AL.
    Gastroenterol Clin North Am; 1989 Mar 25; 18(1):35-42. PubMed ID: 2563990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.